Previous 10 | Next 10 |
2023-08-09 15:44:20 ET More on Azenta Azenta, Inc. ( AZTA ) Q2 2023 Earnings Call Transcript Azenta: Delivering Solid Growth In Life Sciences Azenta: A Second Assessment Azenta hits 52-week low after Q2 miss Azenta surges 28% as FQ4 earnings climb...
2023-08-09 10:08:11 ET Gainers: Tango Therapeutics ( TNGX ) +137% . Decibel Therapeutics ( DBTX ) +72% . Mirati Therapeutics ( MRTX ) +26% . Azenta ( AZTA ) +25% . Clover Health Investments ( CLOV ) +18 % . Losers: ...
2023-08-08 16:39:14 ET Azenta press release ( NASDAQ: AZTA ): FQ3 Non-GAAP EPS of $0.13 beats by $0.15 . Revenue of $166M (+24.8% Y/Y) beats by $12.67M . Shares +9.75% . Guidance for Fourth Quarter Fiscal 2023 Total revenue is expected to be in th...
Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023 PR Newswire BURLINGTON, Mass. , Aug. 8, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2023. Ma...
Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast PR Newswire BURLINGTON, Mass. , Aug. 3, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2023 earnings which ended on June 30, 2023 on Tuesday...
2023-07-26 20:31:51 ET Summary Azenta Life Sciences, a key player in the life sciences industry, is poised for financial recovery with a robust Q2 performance and cost-cutting measures, making it an enticing investment opportunity. The company's product portfolio includes automate...
2023-06-29 16:37:10 ET Azenta ( NASDAQ: AZTA ) said on Thursday that it is opening a new, 40,000 square foot facility, in the greater Boston area. The site, located in Billerica, Massachusetts, is expected to begin working towards the end of 2023. Facility will be AZT...
Azenta Announces New Biorepository in the Greater Boston Area PR Newswire Azenta has selected the greater Boston area, a key pharma and biotech hub, as the next location to expand its global biorepository footprint. BURLINGTON, Mass. , June 29, 2023 /...
2023-06-16 13:10:02 ET Summary Today, we take our second look at a life sciences concern called Azenta, Inc. The company has a massive cash hoard, is buying back a huge amount of stock, but sales growth is slowing, and valuations appear stretched even after a recent pullback. ...
Azenta Announces Collaboration with the Lupus Research Alliance to Support the Advancement of Lupus Research and Drug Discovery PR Newswire Azenta has been Selected by the Lupus Research Alliance as its Sample Management Services Provider and Partner in Supporting the Developm...
News, Short Squeeze, Breakout and More Instantly...
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast PR Newswire BURLINGTON, Mass. , July 24, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024 , on Tues...
FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study PR Newswire Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass. , July 22, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) t...
2024-07-20 00:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...